3,235
Views
47
CrossRef citations to date
0
Altmetric
Research Paper

DNA methylation biomarkers for head and neck squamous cell carcinoma

, , , , , , & show all
Pages 398-409 | Received 26 Jan 2018, Accepted 10 Apr 2018, Published online: 10 Aug 2018

References

  • Pai SI, Westra WH. Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu Rev Pathol. 2009;4:49–70. PubMed PMID: 18729723; PubMed Central PMCID: PMCPMC3703474.
  • Vokes EE, Weichselbaum RR, Lippman SM, et al. Head and neck cancer. N Engl J Med. 1993 Jan 21;328(3):184–194. PubMed PMID: 8417385.
  • Society AC. Cancer facts and figures, 2018. [cited 2018 Jan 04]. Available from: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2018/cancer-facts-and-figures-2018.pdf
  • Arantes L, De Carvalho AC, Melendez ME, et al. Serum, plasma and saliva biomarkers for head and neck cancer. Expert Rev Mol Diagn. 2018 Jan;18(1):85–112. PubMed PMID: 29134827.
  • Carvalho AL, Nishimoto IN, Califano JA, et al. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer. 2005 May 1;114(5):806–816. PubMed PMID: 15609302.
  • Cmelak AJ, Arneson K, Chau NG, et al. Locally advanced head and neck cancer. Am Soc Clin Oncol Educ Book. 2013;237–244. PubMed PMID: 23714512. doi:10.1200/EdBook_AM.2013.33.237
  • Matar N, Haddad A. New trends in the management of head and neck cancers. J Med Liban. 2011 Oct-Dec;59(4):220–226. PubMed PMID: 22746011.
  • Argiris A, Eng C. Epidemiology, staging, and screening of head and neck cancer. Cancer Treat Res. 2003;114: 15–60. PubMed PMID: 12619537.
  • Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988 Jun 1;48(11):3282–3287. PubMed PMID: 3365707.
  • Vineis P, Alavanja M, Buffler P, et al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst. 2004 Jan 21;96(2):99–106. PubMed PMID: 14734699.
  • D’Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007 May 10;356(19):1944–1956. PubMed PMID: 17494927.
  • Kreimer AR, Clifford GM, Boyle P, et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):467–475. PubMed PMID: 15734974.
  • O’Rorke MA, Ellison MV, Murray LJ, et al. Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol. 2012 Dec;48(12):1191–1201. PubMed PMID: 22841677.
  • Munger K, Howley PM. Human papillomavirus immortalization and transformation functions. Virus Res. 2002 Nov;89(2):213–228. PubMed PMID: 12445661.
  • Slebos RJ, Yi Y, Ely K, et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):701–709. PubMed PMID: 16467079.
  • Marsit CJ, Christensen BC, Houseman EA, et al. Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma. Carcinogenesis. 2009 Mar;30(3):416–422. PubMed PMID: 19126652; PubMed Central PMCID: PMCPMC2650795.
  • Worsham MJ, Chen KM, Meduri V, et al. Epigenetic events of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2006 Jun;132(6):668–677. PubMed PMID: 16785414.
  • Bird AP. CpG-rich islands and the function of DNA methylation. Nature. 1986 May 15–21;321(6067):209–213. PubMed PMID: 2423876.
  • Tate PH, Bird AP. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr Opin Genet Dev. 1993 Apr;3(2):226–231. PubMed PMID: 8504247.
  • Dong SM, Sun DI, Benoit NE, et al. Epigenetic inactivation of RASSF1A in head and neck cancer. Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3635–3640. PubMed PMID: 14506151.
  • Liu Z, Zhao J, Chen XF, et al. CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer. Lung Cancer. 2008 Oct;62(1):15–22. PubMed PMID: 18358560.
  • Rosas SL, Koch W, da Costa Carvalho MG, et al. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res. 2001 Feb 1;61(3):939–942. PubMed PMID: 11221887.
  • Takahashi T, Shigematsu H, Shivapurkar N, et al. Aberrant promoter methylation of multiple genes during multistep pathogenesis of colorectal cancers. Int J Cancer. 2006 Feb 15;118(4):924–931. PubMed PMID: 16108009.
  • Delpu Y, Cordelier P, Cho WC, et al. DNA methylation and cancer diagnosis. Int J Mol Sci. 2013 Jul 18;14(7):15029–15058. PubMed PMID: 23873296; PubMed Central PMCID: PMCPMC3742286.
  • Zhang XM, Guo MZ. The value of epigenetic markers in esophageal cancer. Front Med China. 2010 Dec;4(4):378–384. . PubMed PMID: 21107750.
  • Sanchez-Cespedes M, Esteller M, Wu L, et al. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res. 2000 Feb 15;60(4):892–895. PubMed PMID: 10706101.
  • Steinmann K, Sandner A, Schagdarsurengin U, et al. Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma. Oncol Rep. 2009 Dec;22(6):1519–1526. PubMed PMID: 19885608.
  • Kulasingam V, Diamandis EP. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Clin Pract Oncol. 2008 Oct;5(10):588–599. PubMed PMID: 18695711.
  • Chung CH, Parker JS, Karaca G, et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell. 2004 5;May(5):489–500. PubMed PMID: 15144956.
  • Demokan S, Chuang AY, Chang X, et al. Identification of guanine nucleotide-binding protein gamma-7 as an epigenetically silenced gene in head and neck cancer by gene expression profiling. Int J Oncol. 2013 Apr;42(4):1427–1436. PubMed PMID: 23403885; PubMed Central PMCID: PMCPMC3981008.
  • Roepman P, Wessels LF, Kettelarij N, et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet. 2005 Feb;37(2):182–186. PubMed PMID: 15640797.
  • Calmon MF, Colombo J, Carvalho F, et al. Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer. Cancer Genet Cytogenet. 2007 Feb;173(1):31–37. PubMed PMID: 17284367.
  • Viswanathan M, Tsuchida N, Shanmugam G. Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Int J Cancer. 2003 May 20;105(1):41–46. . PubMed PMID: 12672028.
  • Yalniz Z, Demokan S, Suoglu Y, et al. Simultaneous methylation profiling of tumor suppressor genes in head and neck cancer. DNA Cell Biol. 2011 Jan;30(1):17–24. PubMed PMID: 20860434.
  • Aryee MJ, Jaffe AE, Corrada-Bravo H, et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics. 2014 May 15;30(10):1363–1369. PubMed PMID: 24478339; PubMed Central PMCID: PMCPMC4016708.
  • Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015 Apr 20;43(7):e47. PubMed PMID: 25605792; PubMed Central PMCID: PMCPMC4402510.
  • Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 1996 Jun 1;56(11):2488–2492. PubMed PMID: 8653682.
  • Field JK. Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck. Eur J Cancer B Oral Oncol. 1992 Jul;28B(1):67–76 PubMed PMID: 1330149.
  • Field JK. The role of oncogenes and tumour-suppressor genes in the aetiology of oral, head and neck squamous cell carcinoma. J R Soc Med. 1995 Jan;88(1):35P–39P. PubMed PMID: 7884768; PubMed Central PMCID: PMCPMC1295074.
  • Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet. 2006 Jan;7(1):21–33. PubMed PMID: 16369569.
  • Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002 Jun;3(6):415–428. PubMed PMID: 12042769.
  • Nephew KP, Huang TH. Epigenetic gene silencing in cancer initiation and progression. Cancer Lett. 2003 Feb 20;190(2):125–133. PubMed PMID: 12565166.
  • Nakao M. Epigenetics: interaction of DNA methylation and chromatin. Gene. 2001 Oct 31;278(1–2):25–31. PubMed PMID: 11707319.
  • Strahl BD, Allis CD. The language of covalent histone modifications. Nature. 2000 Jan 6;403(6765):41–45. PubMed PMID: 10638745.
  • Miracca EC, Kowalski LP, Nagai MA. High prevalence of p16 genetic alterations in head and neck tumours. Br J Cancer. 1999 Oct;81(4):677–683. PubMed PMID: 10574255; PubMed Central PMCID: PMCPMC2362902.
  • Esteller M, Corn PG, Baylin SB, et al. A gene hypermethylation profile of human cancer. Cancer Res. 2001 Apr 15;61(8):3225–3229. PubMed PMID: 11309270.
  • Olasz J, Juhasz A, Remenar E, et al. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age. Oncol Rep. 2007 Jul;18(1):105–112. PubMed PMID: 17549354.
  • Hasegawa M, Nelson HH, Peters E, et al. Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene. 2002 Jun 20;21(27):4231–4236. PubMed PMID: 12082610.
  • Weber A, Hengge UR, Bardenheuer W, et al. SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. Oncogene. 2005 Oct 6;24(44):6699–6708. PubMed PMID: 16007169.
  • Tripathi Bhar A, Banerjee S, Chunder N, et al. Differential alterations of the genes in the CDKN2A-CCND1-CDK4-RB1 pathway are associated with the development of head and neck squamous cell carcinoma in Indian patients. J Cancer Res Clin Oncol. 2003 Nov;129(11):642–650. PubMed PMID: 14586645.
  • Worsham MJ, Stephen JK, Chen KM, et al. Delineating an epigenetic continuum in head and neck cancer. Cancer Lett. 2014 Jan 28;342(2):178–184. PubMed PMID: 22388100; PubMed Central PMCID: PMCPMC3371397.
  • Li J, Zhou C, Ni S, et al. Methylated claudin-11 associated with metastasis and poor survival of colorectal cancer. Oncotarget. 2017 Nov 10;8(56):96249–96262. PubMed PMID: 29221203; PubMed Central PMCID: PMCPMC5707097.
  • Li J, Zhou C, Wang G, et al. Promoter hypermethylation of SLIT2 is a risk factor and potential diagnostic biomarker for nasopharyngeal carcinoma. Gene. 2017 Nov 8 PubMed PMID: 29107007. DOI:10.1016/j.gene.2017.10.059.
  • Shen Z, Zhou C, Li J, et al. SHISA3 Promoter methylation is a potential diagnostic and prognostic biomarker for laryngeal squamous cell carcinoma. Biomed Res Int. 2017;2017:9058749. PubMed PMID: 28299336; PubMed Central PMCID: PMCPMC5337399. publication of this article.
  • Sailer V, Gevensleben H, Dietrich J, et al. Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma. PLoS One. 2017;12(6):e0179412. PubMed PMID: 28617833; PubMed Central PMCID: PMCPMC5472307.
  • Schneider BG, Mera R, Piazuelo MB, et al. DNA Methylation predicts progression of human gastric lesions. Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1607–1613. PubMed PMID: 26269563; PubMed Central PMCID: PMCPMC4592454.
  • Schneider BG, Piazuelo MB, Sicinschi LA, et al. Virulence of infecting Helicobacter pylori strains and intensity of mononuclear cell infiltration are associated with levels of DNA hypermethylation in gastric mucosae. Epigenetics. 2013 Nov;8(11):1153–1161. PubMed PMID: 24128875; PubMed Central PMCID: PMCPMC3927747.
  • Urrutia R. KRAB-containing zinc-finger repressor proteins. Genome Biol. 2003;410:231. PubMed PMID: 14519192; PubMed Central PMCID: PMCPMC328446.
  • Tian C, Xing G, Xie P, et al. KRAB-type zinc-finger protein Apak specifically regulates p53-dependent apoptosis. Nat Cell Biol. 2009 May;11(5):580–591. PubMed PMID: 19377469.
  • Cancer Genome Atlas Research N. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014 Sep 11;513(7517):202–209. PubMed PMID: 25079317; PubMed Central PMCID: PMCPMC4170219.
  • Song Y, Li L, Ou Y, et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature. 2014 May 1;509(7498):91–95. PubMed PMID: 24670651.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.